17 completed, 4 unknown, 1 active not recruiting, 1 not yet recruiting. 10 Phase 2, 7 Not applicable, 4 Phase 3, 3 Phase 4, 1 Early Phase 1.
Follow Ringer's Solution: new trials by email Literature Review of Ringer's Solution trials Research Report on Ringer's Solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra-articular Injection of Medications in TMJ After Arthrocentsis Arthrocentesis with ringer solution - Internal Derangement | Not applicable | Not yet recruiting | Cairo University | 20 | 2026-06-01 | 2026-05-22 |
| EFFECT OF TMJ ARTHROCENTESIS ON ARTICULAR CAPSULAR WIDTH: AN ULTRASONOGRAPHIC STUDY Arthrocentesis with ringer solution - TEMPOROMANDIBULAR JOINT DISORDER | Not applicable | Completed | Yuzuncu Yil University | 27 | 2025-03-01 | 2026-04-27 |
| Lavage With Super-Oxidized Solution for Secondary Peritonitis Super-oxidized solution (SOS), Ringer's solution - Peritonitis | Not applicable | Unknown | Insel Gruppe AG, University Hospital Bern | 200 | 2023-03-21 | 2024-01-11 |
| MESNA Injection for TMJ Internal Derangement Mesna Injection, Arthrocentesis with ringer solution - TMJ Disorder | Not applicable | Completed | Tanta University | 60 | 2023-03-01 | 2025-07-24 |
| Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19 Reamberin, Ringer's solution - COVID-19 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 105 | 2020-12-01 | 2024-12-19 | |
| Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19) Tissue plasminogen activator, Ringer solution - Acute Respiratory Distress Syndrome | Phase 3 | Withdrawn | Negovsky Reanimatology Research Institute | 2020-10-15 | 2021-03-12 | |
| Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears Autologous Stomal Vascular Fraction Material, Ringer's solution - Rotator Cuff Tear, Muscle Atrophy | Phase 2 | Active not recruiting | Hospital for Special Surgery, New York | 56 | 2019-07-01 | 2026-09-03 |
| Effect of Different Infusion Volume on Perioperative Bladder and Blood Volume in Patients Undergoing Daytime Surgery. Ringer's solution acetate - Cholecystolithiasis and Thyroid Nodule | Not applicable | Completed | China Medical University, China | 90 | 2019-06-19 | 2022-05-13 |
| The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section Norepinephrine, Phenylephrine, Ringer's Solution - Cesarean Section Complications | Phase 2 / Phase 3 | Completed | China International Neuroscience Institution | 238 | 2019-02-20 | 2020-02-10 |
| Is the Combine Prolotherapy More Effective Than the Traditional Prolotherapy in Patients With Temporomandibular Joint Hypermobility? prolotherapy solution of 20% dextrose, Arthrocentesis with ringer solution - Temporomandibular Disorders (TMD), Temporomandibular Pain | Phase 4 | Completed | Karadeniz Technical University | 26 | 2019-01-01 | 2025-06-13 |
| Effect of Ocular Hygiene on Scleral Lens Wear Ringers Solution, Placebo - Concentrate - Scleral Contact Lenses | Early Phase 1 | Unknown | University of Houston | 24 | 2018-05-18 | 2018-06-01 |
| "Unifuzol®" in Patients With Peripheral Arterial Disease L-arginine 1.4% 500 ml, L-arginine 1.4% 250 ml + placebo 250 ml, Placebo solution - Peripheral Arterial Disease | Phase 2 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 360 | 2018-03-16 | 2020-01-31 |
| Remaxol® in Mechanical Jaundice of Non-malignant Origin Remaxol (succinate + methionine + inosine + nicotinamide), Ringer's Solution - Jaundice, Obstructive | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 342 | 2017-04-03 | 2020-07-14 |
| Remaxol® in Malignant Mechanical Jaundice Remaxol®, Ringer's Solution - Jaundice; Malignant | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 240 | 2017-04-03 | 2020-07-10 |
| Validation of Nicom Device to Measure Stoke Volume Variation Volume loading, Ringer solution - Anesthesia | Not applicable | Terminated | Hopital Foch | 2 | 2015-06-28 | 2018-01-29 |
| Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery Glutamine, Ringer's solution - Rheumatic Heart Disease, Coronary Heart Disease | Phase 2 | Completed | Yuejiang Liu | 33 | 2013-01-01 | 2014-05-28 |
| Prehospital COOLing 1 (PreCOOL 1) Cold crystalloid infusions, 0.9%NaCl or Ringer's solution - Stroke | Phase 2 | Unknown | University Hospital Heidelberg | 40 | 2012-09-01 | 2013-06-24 |
| A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Flex.Pads (iCOOL 2) Cold crystalloid infusions, 0.9%NaCl or Ringer's solution, EMCOOLS Flex.Pads - Ischemic Stroke, Hemorrhagic Stroke | Phase 2 | Unknown | University Hospital Heidelberg | 20 | 2012-01-01 | 2013-06-24 |
| A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. RhinoChill (iCOOL 1) RhinoChill, Cold crystalloid infusions, 0.9%NaCl or Ringer's solution - Ischemic Stroke, Hemorrhagic Stroke | Phase 2 | Completed | University Hospital Heidelberg | 20 | 2010-09-01 | 2012-04-26 |
| The Antiseptic Efficacy and Tolerability of Lavasept® 0.04% on Acute Traumatic Wounds Lavasept 0.04%, Ringer's Solution - Wounds | Phase 4 | Completed | B. Braun Ltd. Centre of Excellence Infection Control | 61 | 2010-08-01 | 2012-04-06 |
Showing 20 of 25. Sign in to see all of them.
Hemorrhagic Stroke (3) · Hypothermia (3) · Ischemic Stroke (3) · Stroke (3) · Temporomandibular Joint Disorders (3) · COVID-19 (2) · Cerebrovascular Disorders (2) · Intracranial Hemorrhages (2) · Jaundice, Obstructive (2) · Agnosia (1) · Arterial Occlusive Diseases (1) · Blood Loss, Surgical (1) · Cholecystolithiasis (1) · Coronary Disease (1) · Dysmenorrhea (1)
POLYSAN Scientific & Technological Pharmaceutical Company (4) · University Hospital Heidelberg (3) · Sangart (2) · B. Braun Ltd. Centre of Excellence Infection Control (1) · Cairo University (1) · China International Neuroscience Institution (1) · China Medical University, China (1) · Hopital Foch (1) · Hospital for Special Surgery, New York (1) · Insel Gruppe AG, University Hospital Bern (1) · Isifer AB (1) · Karadeniz Technical University (1) · Nanjing Medical University (1) · Negovsky Reanimatology Research Institute (1) · Regina Elena Cancer Institute (1)
China (4) · Russia (4) · Germany (3) · United States (3) · Egypt (2) · Sweden (2) · Switzerland (2) · Turkey (Türkiye) (2) · France (1) · Italy (1)
Sven Poli, Dr. med. (3) · Mikhail S. Bogomolov, MD, PhD (2) · Christina I. Olofsson, MD, PhD (1) · Erik Popp, PD Dr. med. (1) · Ester Forastiere, M.D. (1) · Greta Edelstam, MD (1) · Hans Peter Simmen, MD (1) · John Ulatowski, M.D., Ph.D. (1) · Mikhail S Bogomolov, MD, PhD (1) · Mohamed Ashraf Eissa, Assisstant professor (1) · Peter E. Keipert, Ph.D. (1) · Scott Rodeo, MD (1) · Tianlong Wang, MD,PHD (1) · Tobias Haltmeier, MD (1)
PMID 17122578, PMID 1941330, PMID 19546260, PMID 19875361, PMID 20188998, PMID 21703585, PMID 21757278, PMID 22232129, PMID 22487806, PMID 23524704, PMID 23921822, PMID 24064304, PMID 25346332, PMID 25806865, PMID 26846795, PMID 28439165, PMID 28460873, PMID 28844356, PMID 29017019, PMID 29533255, PMID 30024045, PMID 32894044, PMID 33326351, PMID 33584052, PMID 36523721, PMID 39115583, PMID 41188164, PMID 42226174